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Aquaporins (AQPs) facilitate water transport across epithelia
and play an important role in normal physiology and disease
 




 hybridization and im-
munofluorescence to determine the expression and cellular
localization of AQPs 5, 4, and 3 in human airway sections. In
nose and bronchial epithelia, AQP5 is expressed at the apical
membrane of columnar cells of the superficial epithelium and
submucosal gland acinar cells. AQP4 was detected in basolat-




 in gland acinar
cells. AQP3 is present on basal cells of both superficial epithe-
 
lium and gland acinus. In these regions AQPs 5, 4, and 3 are ap-
propriately situated to permit transepithelial water permeabil-
ity. In the small airways (proximal and terminal bronchioles)
AQP3 distribution shifts from basal cell to surface expression
(i.e., localized to the apical membrane of proximal and termi-
nal bronchioles) and is the only AQP identified in this region
of the human lung. The alveolar epithelium has all three AQPs
represented, with AQP5 and AQP4 localized to type I pneu-
mocytes and AQP3 to type II cells. This study describes an in-
tricate network of AQP expression that mediates water trans-
port across the human airway epithelium.
 
Water transport across pulmonary epithelia is a vital com-
ponent of lung physiology. In proximal airways, transepi-
thelial water movement replaces insensible water loss; in
the perinatal period, water is reabsorbed across the alveo-




life; and in all airway regions, transepithelial water flux is
responsible for maintenance of an isotonic airway surface
liquid (ASL) (1–8). Water transit across cell membranes





) with the direction of flow determined
by the orientation of the osmotic gradient (9, 10). Perhaps
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cm/s. Biophysical studies in whole-lung preparations of














 cm/s across alveolar epithelial barriers (8–




 is consistent with transcellular water flow
through molecular water channels, aquaporins (AQPs) (7–





measured in proximal convoluted segments of renal tubu-
lar epithelium (mainly AQP1) and distal collecting ducts
(AQP2), where the antidiuretic function of AQPs in nor-
mal physiology and disease are well established (8–10, 13).
AQPs are integral membrane proteins that function as
molecular water channels in a variety of fluid transporting
tissues. To date 10 mammalian AQP proteins, AQP0 to
AQP9, have been identified (8–10, 13). AQP isoforms
have a distinctive tissue distribution and cellular expres-
sion pattern (e.g., apical versus basolateral membrane in
epithelia) and permit rapid and specific water transport in
response to osmotic gradients. Immunocytochemistry and
messenger RNA (mRNA) expression studies of AQPs have
revealed that only four of the known AQPs are present in
the rodent airway (14). AQP1 is abundantly expressed in
the plasma membrane of endothelial cells of the microvas-
culature and visceral pleura. AQP5, a mercury-sensitive wa-
ter channel, has been found primarily in the apical mem-
brane of type I alveolar pneumocytes and submucosal gland
acinar cells in the upper airways. AQP4, a non–mercury
sensitive water channel, has been localized to the basolat-
eral membrane of columnar cells in the superficial epithe-
lium lining the upper airways. AQP3, a water channel that
has a high permeability for glycerol, appears to be expressed
predominately in the plasma membrane of basal cells in
the proximal airways (tracheal region) (8–10, 13, 14). This
discrete, predominately nonoverlapping distribution sug-
gests a functional specialization for AQPs in different re-
gions of the mammalian airways. Interestingly, no AQPs
have yet been identified in three airway locations impor-









) small airways, both psuedostrati-





basolateral membrane of type I alveolar cells or in either
membrane of type II pneumocytes.
In spite of the recognized role of ASL in human airway
diseases and the fundamental contribution of AQPs to the
homeostasis of the ASL, few studies have addressed water
permeation (or AQP function) across human airway epi-
thelia. Previous studies in human nasal and bronchial cul-




 across these epithelia suggest-
ing a role for AQPs, but did not search for specific AQPs
to account for these permeabilities (1, 6). The present study
examines the tissue distribution and cellular localization of
the reported lung epithelial AQPs, i.e., AQP3, AQP4, and





bridization (ISH) and immunofluorescence (IF) studies of
nasal epithelia and different caliber intrathoracic airway
segments, and determined expression in lumenal, glandu-
lar, and alveolar epithelia. Our findings reveal extensive
AQP distribution in airway and air-space epithelia, suggest-
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the network of water channels that mediate water conduc-






Human nasal sections were obtained from patients undergoing
rhinologic procedures (e.g., turbinectomy). Upper and lower air-
ways were obtained from excess tissue from donor lungs of pa-
tients involved in lung transplantation. All human tissue proto-
cols were reviewed and approved by the University of North
Carolina Committee for the Protection of the Rights of Human
Subjects. Tissues were rapidly dissected from several regions
(bronchi, trachea, bronchioles, and alveolar epithelia) and fresh-
frozen directly in OCT embedding compound, typically within 30
min of tissue resection. Distal airway sections were frozen after








C until used for ISH or IF studies. For these studies, thin




m) were cut by a cryothome, mounted on glass












Intrathoracic respiratory segments were classified into three cate-




) the relatively large di-
ameter and presence of cartilage and mucosal glands subjacent to





) bronchioles or “small airways” were characterized as
noncartilagenous and aglandular airways lined with pseudostrati-
fied epithelium (proximal bronchioles) or simple cuboidal epithe-




) the alveolar compartment.
 
Human Complementary DNA Library
Construction and Screening
 
Trachea and third- to sixth-generation airways were dissected
from a human lung donor tissue sample and incised longitudi-
nally. Guanidine thiocyanate was applied directly to the surface
epithelium for 1 to 2 min and the epithelial digest was removed
by scraping the surface with a glass slide. RNA was isolated by
CsCl centrifugation and confirmed by gel electrophoresis. Micro-
scopic examination of the tissue sections established that the su-
perficial epithelium was effectively removed from the underlying
structure. Isolated RNA was reverse transcribed and a comple-
mentary DNA (cDNA) library was constructed using the ZAP-
cDNA Synthesis Kit (Stratagene, La Jolla, CA) as previously de-
scribed. Two oligonucleotide probes were designed targeting con-
sensus sequences for the mercury-sensitive region of the known




-T(A/T)C AC(T/C) GGC TG(T/C)









-T(A/T)C AC(T/C) GGC TG(T/C) GGG ATT




. The probes were ra-



















Total RNA was isolated from superficial epithelium of large air-
ways or from whole-lung specimens obtained as described ear-




g, was resolved on a formaldehyde agarose
gel and transferred to nylon membranes according to manufac-









P] deoxycytidine triphosphate (dCTP)–radiolabeled





 the following section). Blots were visualized by au-
toradiography, and 18S and 28S ribosomal bands were visualized




Cryosections were fixed in 4% paraformaldehyde for 1 h, dehy-









C for 30 min. Tissue sections





 Denhardt’s solution, 0.6 M NaCl, 1 mM























S-CTP–labeled sense or antisense riboprobes, con-




 counts per min/ml, corresponding to the cod-
ing sequence of AQP5 (base pairs [bp] 156–905), AQP4 (bp 156–









polymerase. After washing and ribonuclease treatment, tissue
sections were exposed to photographic emulsion for 7 to 10 d.
Sections were counterstained with hematoxylin and eosin (H&E)
for light microscopic examination. A Nikon microphot SA micro-
scope connected to a 3CC-Chilled Camera (Sony, Marietta, GA)







. A polyclonal antibody to AQP5 was generated





COOH) corresponding to the carboxy terminal 16 amino acids of
the human AQP5. The peptide was crosslinked to keyhole limpet
hemocyanin (UNC Peptide Synthesis Facility, Chapel Hill, NC)
and injected into New Zealand White rabbits (Bethyl Corp., Mont-
gomery, TX). Polyclonal anti-AQP5 immunoglobulin (Ig) G was
purified from serum using affinity chromatography. Affinity-puri-
fied, peptide-derived antibodies against AQP4 and AQP3 were gen-
erously provided by Dr. Mark Knepper (National Institutes of
Health, Bethesda, MD) and have been previously described (15, 16).
 
Primary antibody (source, dilution)
 
. Affinity-purified human
AQP5 (Bethyl; 1/50–1/100 dilution); rat AQP5 (Chemicon, Temec-
ula, CA; 1/100–1/200); rat AQP3 (Dr. M. Knepper; 1/75); rat AQP3
(Chemicon; 1/100–1/200); rat AQP4 (Dr. M. Knepper; 1/50–1/200,
two different AQP4s synthesized by Dr. Knepper were indepen-
dently tested); rat AQP4 (Chemicon; 1/50–1/200); rat pro–surfac-
tant protein (SP) C (Dr. J Whitsett, University of Cincinnati, Cin-




Frozen tissue sections were fixed in 4% paraformaldehyde at room








C (4 min) followed by blocking in 20% goat serum in 50 mM
sodium phosphate (pH 7.4) and 150 mM NaCl for 3 h. Tissue sec-
tions were incubated in primary antiserum (described later) or
pooled normal rabbit IgG diluted 1:50 in phosphate-buffered saline




C. The tissue was washed in PBS and incubated
with Texas Red–conjugated goat antirabbit IgG (Jackson Immu-
noResearch, West Grove, PA) for 1 h at room temperature (spe-
cific signal stains red). Tissues were mounted in Vectashield con-
taining 4,6-diamidino-2-phenylindole to label nuclei blue (Vector
Laboratories, Burlingame CA). Photomicrographs were taken us-
ing a Leica TCS 4D confocal microscope at powers indicated in the
figure captions. In some instances, a Leica DMIRB epifluorescence
microscope connected to a 3CC-Chilled Camera (Shamamatsu, Ra-
leigh, NC) was used to examine tissue sections. All images were
captured and analyzed using AdobePhotoshop and MetaMorph
(Universal Systems, West Chester, PA) imaging programs.
 
Acquisition and Analysis of Data
 
AQP ISH and immunostaining studies were performed in dupli-
cate or triplicate using tissues obtained from different donors for
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were performed in parallel on the same histologic tissue block
obtained from each lung region. Repeat experiments would then
use a different tissue block (different donor, same region) to con-
firm ISH and immunostaining results. Three researchers inde-
pendently scored the level of AQP expression and determined
cell identification and intracellular localization for each AQP in
each lung section studied. Acquired images are representative of




Human cDNA Library Screening and Northern Analysis
 
Screening the human cDNA lung epithelial library with
oligonucleotide primers designed to identify mercury-sen-
sitive water channels yielded greater than 100 positive
clones. AQP5 was identified 59 times and AQP1 was iden-
tified four times. A total of 24 miscellaneous, nonspecific
genes were cloned; 14 previously uncloned genes were also
identified. None of these, however, had any homology to
known AQP sequences.
 
On the basis of these cloning results we proceeded to
evaluate the expression and localization of AQP5 in the
human airways. Northern blot analysis of total RNA from
whole human lung showed a single prominent band at 1.6
kb, corresponding to the previous reported length of the
AQP5 transcript (18). Various animal models of AQP ex-
pression and function have demonstrated the presence of
AQP4 and AQP3 in the airways. We therefore included
AQP4 and AQP3 in our analysis of human airway AQP.
Northern blots of RNA derived from the superficial epi-
thelium of human large airways detected single unique





and AQP3 (1.2 kb). Polymerase chain reaction fragments
generated from these two products were sequence-ana-
lyzed and confirmed the identity of AQP4 and AQP3, re-
spectively (data not shown). Although we did detect AQP1
expression in our library screen we chose not to evaluate
this AQP because it has been shown to have predominately
an endothelial expression pattern in the lung.
Figure 1. Expression of AQP5 and AQP3 in human nasal epithelium. (A) In situ hybridization of AQP5 in nasal tissue. Left panel cor-
responds to a brightfield (H&E) nasal tissue section incubated with the AQP5 antisense probe. Center and right panels are darkfields of
consecutive tissue sections hybridized with AQP5 antisense and sense 35S-labeled probes, respectively. Hybridization conditions, photo-
graphic emulsion exposure, and image acquisitions were identical for both probes. Original magnification: 3100. (B) IF of AQP5 and
AQP3 in nasal epithelium (upper panel: superficial epithelium; lower panel: gland acinus). Left images are stained with H&E, second
images are sections stained with AQP5 antibodies, third images are sections immunostained with antibodies against rat-AQP3, and right
images correspond to consecutive sections incubated with a nonimmune rabbit IgG (Control). Immunofluorescence images were ac-
quired by xy confocal scanning microscopy (z z 1 mm). Original magnification: 3800 (upper panel), 31,500 (lower panel). In this and all
subsequent figures, L indicates lumen.
 
 








ISH with AQP5 antisense riboprobes revealed a discrete
pattern of expression in nasal epithelium. AQP5 hybrid-
ization revealed robust mRNA expression in the superfi-
cial epithelium (Figure 1A). Strong signal was also present
in clusters of subepithelial glands, where the signal was con-
fined to acinar structures. Similar tissue sections were studied
by IF using two antibodies directed against the C-terminus of
AQP5. Both antibodies generated strong immunoreactiv-
ity signals at the apical membrane of all columnar cells fac-
ing the lumenal surface of the superficial epithelium, and
also at the apical membrane of serous cells in all the sub-
mucosal gland acini (Figure 1B). Strong expression of AQP3
was also observed in the superficial nasal epithelium by IF
(
 
third column in both rows
 
 of Figure 1B). The distribution
of AQP3 appeared to be localized to the plasma membrane
of all basal cells in the superficial epithelia, as well as the
basal cells of some serous gland acini. Nonimmune controls
were negative.
Expression of AQP4 was not detected in nasal epithelia
either by ISH or by IF analyses, using several different an-




ISH studies of AQP5 in human bronchial tissue revealed
prominent expression in the superficial epithelium and in
submucosal glandular epithelium in the acinar portion of
the glands (Figure 2A). No signal was seen in cartilaginous,
vascular, interstitial, or any other cell types, and the sense
riboprobe showed no signal above background. AQP5 IF
was not routinely detected in the superficial epithelium. IF
analysis of the same bronchial tissues showed specific AQP5
signal in the apical membrane of ciliated duct columnar cells,
as well as at the apical membrane of serous cells in submu-
cosal gland acini (Figure 2B). Nonimmune controls were
negative.
ISH with an AQP4 riboprobe showed a mRNA expres-
sion pattern similar to that of AQP5, i.e., pronounced sig-
nal in both superficial and submucosal epithelium (Figure
3A). AQP4 expression was strongest in the submucosal
glands where the signal was confined to the acini, and ex-
pression was less distinct although clearly present in the su-
perficial epithelium. IF studies were unable to detect AQP4
immunoreactivity in the superficial or glandular epithelium.
We did, however, observe AQP4 immunostaining in the ba-
Figure 2. AQP5 expression in hu-
man bronchus. (A) In situ hybrid-
ization of AQP5 in bronchial epi-
thelium. All three images are
consecutive tissue sections; left is
an H&E brightfield; middle and
right images represent sections
hybridized by AQP5 antisense
and sense probes, respectively.
Original magnification: 3100. (B)
AQP5 immunostaining in large
ciliated ducts (upper panel) and
gland acini (lower panel). A box is
drawn in the H&E upper panel to
indicate the area that is magnified
after AQP5 antibody (middle im-
age) and control staining (right
image). IF images were acquired
by xy confocal scanning microscopy
(z z 1 mm). Original magnifica-
tions: upper panel, 3250 (H&E)
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solateral membrane of columnar and intermediate cells of
ciliated ducts (Figure 3B).
AQP3 ISH signal was localized to the lower compart-
ment of the pseudostratified superficial epithelia of bron-
chi (Figure 4A). AQP3 mRNA expression was absent from
proximal portions of ducts and acinar regions of bronchial
submucosal glands. No hybridization signal was seen in other
cell types, and sense riboprobes displayed no specific signal
above background. IF studies confirmed that AQP3 was
highly expressed in the plasma membrane of all basal cells
Figure 3. AQP4 expression in hu-
man bronchus. (A) In situ hybrid-
ization of AQP4 in bronchial epi-
thelium. All three images are
consecutive tissue sections; left is
an H&E brightfield; middle and
right images represent sections hy-
bridized by AQP4 antisense and
sense probes, respectively. Origi-
nal magnification: 3100. (B)
AQP4 immunostaining in the ba-
solateral membranes of columnar
and intermediate cells of large cil-
iated ducts. The inset in the mid-
dle panel is an enlarged area
showing AQP4 staining on the lat-
eral membranes of columnar cells.
IF images were acquired by xy
confocal scanning microscopy (z
z 1 mm). Original magnification:
3400; inset, 3600.
Figure 4. AQP3 expression in hu-
man bronchus. (A) In situ hybrid-
ization of AQP3 in bronchial epi-
thelium. Left image is an H&E
brightfield; middle and right im-
ages represent sections hybridized
by AQP3 antisense and sense
probes, respectively. Original mag-
nification: 3100. (B) Immunostain-
ing with rat-AQP3 antibody in the
membranes of the basal cells of
bronchial epithelium. Original mag-
nification: 3400.
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in the human bronchi (Figure 4B). AQP3 immunolabeling
was not observed in columnar epithelia or any other cell
type. Nonimmune controls confirmed specificity.
Bronchioles
Of the three AQPs evaluated, only AQP3 displayed signif-
icant expression in human bronchiolar tissue. ISH analysis
showed a strong signal in the superficial epithelia (basal
cells) of pseudostratified, proximal bronchioles (Figure 5A).
IF corroborated AQP3 presence in all the basal cells in this
airway segment with intense labeling in the plasma mem-
brane of these cells (Figure 5B). Surprisingly, robust AQP3
immunoreactivity was also observed at the apical membrane
of all the columnar cells facing the lumen (Figure 5C).
In terminal bronchioles, AQP3 ISH revealed extensive
expression in the simple cuboidal epithelium (Figure 6A).
IF confirmed the expression of AQP3 protein (Figure 6B).
Confocal microscopy revealed AQP3 immunostaining at
the apical and basolateral membranes of the cuboidal epi-
thelium (Figure 6C). No signal was detected with antibod-
ies against AQP5 or AQP4 throughout the bronchiolar re-
gion, confirming the absence of signal by ISH for these
AQP. Nonimmune controls were negative.
Alveoli
ISH studies demonstrated that all three AQPs—AQP5,
AQP4, and AQP3—were expressed in the alveoli. AQP5
ISH showed diffuse staining along alveolar cells with no
Figure 5. AQP3 expression in hu-
man pseudostratified bronchiolar
epithelium. (A) In situ hybridiza-
tion of AQP3 in proximal bron-
chioles. Consecutive cross sec-
tions of a proximal bronchiole.
Left image is an H&E brightfield;
middle and right images represent
sections hybridized by AQP3 anti-
sense and sense probes, respec-
tively. Original magnification: 380.
(B) Immunostaining with rat-
AQP3 antibody shows AQP3 ex-
pressed in the apical membrane of
columnar cells facing the lumen,
as well as in the membranes of the
basal cells. Original magnifica-
tion: 3600. (C) Higher magnifica-
tion (32,400) of section shown in
B, with AQP3 immunostaining
specific to apical and basolateral
membrane of columnar cells (up-
per panel) and plasma membranes
of basal cells (lower panel). IF im-
ages in B and C are xy confocal
scanning (z z 1 mm) of the same
field at different focal planes.
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distinct pattern, consistent with expression in type I pneu-
mocytes (Figure 7A). AQP5 immunocytochemistry showed
a similarly random, diffuse pattern of expression in alveo-
lar cells (Figure 7B). We were unable to localize AQP5 im-
munoreactivity to a specific cellular surface in these alveolar
cells.
AQP4 ISH also revealed a diffuse pattern of expression
in the alveolar region (Figure 7C). It was difficult to deter-
mine a particular alveolar cell type that is consistent with
this pattern of expression and which may suggest AQP4
expression in multiple cell types. IF studies with AQP4 an-
tisera were not able to identify a more specific pattern of
cellular expression.
ISH with an AQP3-specific riboprobe in alveoli dis-
played a “cornering” pattern of expression characteristic
of type II pneumocytes (Figure 8A). The pattern of AQP3
immunostaining confirmed the scattered expression seen
by ISH in alveolar tissue (Figure 8B). Strong immunoreac-
tivity was observed exclusively in type II pneumocytes, as
recognized by morphology and immunostaining consecu-
tive sections with an anti-SP (anti–SP-C) antibody, specific
for type II cells (17) (Figure 8B, right panel). Specificity
was determined in all sections with nonimmune controls.
Further analysis of AQP3 and SP-C immunostaining by
confocal microscopy suggested that AQP3 was localized
to the basolateral membrane of type II pneumocytes (Fig-
ure 8C).
Discussion
The principal goal of this study was to determine the dis-
tribution of AQPs in the human airway. Our results (sum-
marized in Table 1) describe an extensive network of AQP
expression in human respiratory epithelia. We have noted
both similarities and differences compared with previous
studies of AQP localization in rodent airways. The inter-
species differences in AQP localization may reflect differ-
ences in lung morphology, whereas the similarities likely
describe the importance of lung liquid clearance in the
mammalian lung. Perhaps the most unique finding of this
Figure 6. AQP3 expression in hu-
man simple cuboidal bronchiolar
epithelium. (A) In situ hybridiza-
tion for AQP3 in terminal bron-
chioles. Left image is an H&E
brightfield; middle and right im-
ages represent sections hybridized
by AQP3 antisense and sense
probes, respectively. Original
magnification: 3100. (B) AQP3
immunostaining of the lumenal
surface of the cuboidal epithelium
(original magnification: 340). (C)
Increased magnification (3800)
of images shown in B to depict
specific AQP3 staining in the api-
cal membrane of the cuboidal
cells (middle panel) as well as in
the basolateral membranes of
these cells (inset: xy confocal scan-
ning, z z 1 mm; original magnifi-
cation: 31,000).
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study is the identification of high levels of AQP3 expres-
sion in lumen-facing cells of the distal airways in contrast
with moderate AQP3 expression in basal cells (non–lumen
facing) of the proximal airways.
Under normal conditions, insensible water losses from
the nose and proximal bronchi during inspiration results in
a slightly hypertonic airway surface liquid (5, 19, 20). These
proximal water losses are accelerated under tachypneic
stress or during the inspiration of cold, dry air (e.g., in win-
ter [19–21]). Measurement of the Pf of cultured epithelial
cells derived from the human proximal airways yielded a
transepithelial Pf of 1.7 3 1022 cm/s. (6). This value is too
large to be accounted for by simple diffusion of water across
the phospholipid bilayer and is consistent with the pres-
ence of water channel(s) in the apical membrane of lumen-
facing cells (7–10, 13). AQP5 may contribute to this Pf and
the pathway for replenishment of evaporative losses and
rapid restoration of proximal airway ASL to a rehydrated
state. This conclusion is strengthened by two separate ex-
perimental results. First, a screen of human tracheal epi-
thelium with a “mercury-binding region” probe identified
AQP5 as the most likely water channel (59 AQP5 clones
out of 101 positives). Second, ISH analysis clearly detected
signal for AQP5 message in both the surface epithelium
and submucosal glands of nasal and bronchial human air-
ways. We were able to confirm AQP5 expression in human
nasal but not bronchial surface epithelial membranes by
IF. We speculate that this difference likely reflects the lower
level of AQP5 expression in bronchial regions where evap-
orative water loss may be less than in nasal regions. More-
over, the studies of Matsui and colleagues in human bron-
chial epithelial cells demonstrated an apical membrane Pf
Figure 7. Expression of AQP5
and AQP4 in human alveolar
epithelium. (A) In situ hybrid-
ization of AQP5 in alveoli. Left
image is an H&E brightfield;
middle and right images repre-
sent sections hybridized by
AQP5 antisense and sense
probes, respectively. Original
magnification: 340. (B) AQP5
specific IF in alveolar cells.
Original magnification: 3120.
(C) In situ hybridization for
AQP4 in alveoli. Left image is
an H&E brightfield; middle and
right images represent sections
hybridized by AQP4 antisense
and sense probes, respectively.
Original magnification: 340. Se-
lected air spaces in this figure and
Figure 8 are indicated with an a.
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value that was only ø 30% sensitive to mercury (AQP5 is
reported to be ø 60% inhibited by mercury) (6). There-
fore, we cannot eliminate the possibility of another, uni-
dentified AQP that may participate along with AQP5 to
facilitate Pf in human bronchi.
A second significant finding in human bronchial epithelial
cells was the expression of AQP4. Previous studies localized
AQP4 to the basolateral membrane of lumen-facing cells of
the rat bronchus (14). Our study detected AQP4 by ISH in
the surface epithelium of bronchial epithelia, but we were
unable to determine a cellular localization using several dif-
ferent AQP4 antibodies. We would speculate that AQP4 is
resident in the basolateral membrane, consistent with the
findings in the rat bronchus. Both ISH and immunostaining
studies also revealed expression of AQP4 in ciliated ducts,
and specifically localized expression to the basolateral mem-
brane of columnar cells. Thus, in certain regions of the large
airways we have observed apical membrane expression of
AQP5 and basolateral expression of AQP4 that may func-
tion in concert to restore water from the submucosal vascula-
ture and protect the epithelia from evaporative dehydration.
AQP3 was localized to basal cells of the pseudostrati-
fied nasal and bronchial epithelia. This localization corre-
lates well with studies from rat lung (14). AQP3 expres-
sion in basal cells may account for the rapid shrinkage and
water efflux in this cell type in response to subepithelial
osmotic gradients (6). AQP3 has been termed an “aqua-
glyceroporin” (like AQP7 and AQP9) because it is capable
of transporting glycerol and urea as well as transporting
water (22–25). A role for AQP3 as a solute channel and the
relevance of this function in human bronchial epithelial
physiology remains to be established, but may be especially
important in basal cells that do not face the airway lumen.
More functional studies are necessary to understand fully
the role of AQP3 in this region of the human airways and
its contribution to lung disease.
We also determined the expression of AQP in proximal
airway submucosal glands. Although the tonic contribu-
Figure 8. AQP3 expression in hu-
man alveolar epithelium. (A) In
situ hybridization of AQP3 in al-
veoli. Left image is an H&E
brightfield; middle and right im-
ages represent sections hybridized
by AQP3 antisense and sense
probes, respectively. Original
magnification: 340. (B) Immu-
nostaining with antibodies against
rat-AQP3 (middle panel) and rat
pro-SPC (right panel). Original
magnification: 3100. (C) xy con-
focal scanning planes (z z 1 mm;
original magnification: 32,000)
with anti-AQP3 antibody (middle
panel) and anti–pro-SPC antibody
(right panel).
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tion of submucosal gland secretions to the ASL is not yet
clearly defined, it is likely to be complex. Acini primarily
secrete liquid, distal ducts may modify the acinar secre-
tions and may decrease tonicity, and ciliated ducts propel
the liquid out to the lumen. In acinar portions of the
glands, we found robust AQP5 expression localized to the
apical membrane of acinar cells. AQP5 has been localized
to this same barrier in rat immunolocalization studies, as
well as to the acinar cells of rat parotid, submandibular,
and lachrymal glands (14, 18, 26). Functional data consis-
tent with a role of AQP5 in gland secretions have been re-
ported from the AQP5 knockout mouse model, which has
glandular secretions that are reduced in volume by 60%
and show have a hypertonic saliva with elevated Na, Cl,
and K levels (27). We also found strong expression of AQP4
in acini and speculate it localizes to basolateral membranes,
as has been shown in rat airway glands (14). These obser-
vations are consistent with the hypothesis that submucosal
glands produce an isotonic solution (acini secrete ions and
water) and that water flow is mediated by AQP4 and AQP5
in series in acinar cells (5).
AQP expression in human small airways (proximal and
terminal bronchioles) revealed a surprising finding. Both
ISH and IF studies detected high levels of expression of
AQP3 but not AQP5 or AQP4. In contrast to larger airways,
expression of AQP3 was not restricted to the membranes
of basal cells but was also found in the apical membrane of
columnar cells of psuedostratified bronchiolar epithelium,
as well as in both membranes of cuboidal cells of the termi-
nal bronchioles. This expression pattern for AQP3 in hu-
man small airways does not appear to have a similar coun-
terpart in animal models. In various animal models, AQP3
was found only in basal cells of multilayered epithelia,
large airways (14, 22, 28), gastrointestinal tract (13, 22, 24),
kidney and urinary tract (7, 22), and skin (22).
The presence of AQP3 in this peripheral region is pre-
dicted to confer a robust volume absorptive capacity to
this epithelium. The qualitative magnitude of AQP3 ex-
pression observed in our studies, as demonstrated by the
intensity of both ISH and IF, is suggestive of a high mem-
brane density of AQP3 and is consistent with functional
studies describing a high membrane Pf of distal airways
measured in microperfusion studies (8). In these noncarti-
lagenous, aglandular airway segments, ASL is postulated
to be transported axially from peripheral to central lung
regions (5, 29). We speculate that net absorption of salt
and water is highest in distal segments, given the volume
load imposed on airways during proximal migration from
the distal sources of liquid secretion, perhaps even includ-
ing the alveoli (29).
Although our primary objective was airway epithelial
water transport, we were able to make certain observa-
tions about AQP expression in the human alveolar region.
Previous studies in rodents have described expression of
AQP5 in alveolar cells, localized to the apical membrane
of type I pneumocytes in the rat lung (14). We also found
AQP5 expressed in type I cells of the human lung by ISH
and IF. In contrast to rodent studies, however, we found
evidence for both AQP4 and AQP3 in the distal human
lung. The ISH AQP4 signal was striking in the alveolar re-
gion with a pattern that could not be unambiguously inter-
preted as specific for either type I or type II cells. We spec-
ulate AQP4 is expressed at least in type I cells because (1)
in all lung cell types studied, AQP5 and AQP4 have been
localized to the same cell type; and (2) ISH indicates a large
percentage of pneumocytes expressing AQP4, greater than
can be accounted for by type II cells alone. ISH patterns for
AQP3 were strongly characteristic of expression in cuboidal
type II pneumocytes. We were able to confirm the mRNA
expression pattern by IF showing AQP3 protein expres-
sion in a “cornering” pattern, consistent with type II cell dis-
tribution. An antibody for the rat pro–SP-C (17) showed
an expression pattern that was nearly identical to that ob-
served with the various AQP3 antisera studied. Thus, we
conclude that AQP3 localizes to type II pneumocytes in the
human lung.
At birth, or after edematous conditions, water absorp-
tion may be induced by increasing the expression level of
TABLE 1




ISH IF ISH IF ISH IF
Nose
Superficial 1 AM of CC (11) ND ND 2 BLM of BC (11)
Glands/ducts 1 AM of GC (11) ND ND 2 BLM of BC (1)
Bronchus
Superficial 1 ND 1 ND 1 Membranes of BC (11)
Glands/ducts 1 AM of CC (ducts) (11) 1 BLM of CC (ducts) (6) ND ND
AM of GC (1)
Bronchiole
Pseudostratified ND ND ND ND 1 AM/BLM of CC (11)
Membranes of BC (11)
Simple–cuboidal ND ND ND ND 1 AM/BLM of CuC (11)
Alveolus 1 Type I cells (1) 1 ND 1 BLM of Type II cells (11)
The data summarize the results from two or three independent experiments using multiple tissue sections, each from a different donor. AM: apical membrane,
BLM: basolateral membrane, CC: columnar cell, BC: basal cell, GC: gland acinus cell, CuC: bronchiolar cuboidal cell, 1: specific ISH signal, ND: signal was below
detectable level, 2: not determined. A semiquantitative analysis of the IF signal is described as negative or low (6), moderate (1), or strong (11) intensity.
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several AQPs (2, 4, 30, 31). It is clear that under many dif-
ferent physiologic conditions, AQPs may play a role in
transepithelial water transport to regulate the volume and
osmolarity of the liquid on the alveolar surface. The role
that type I and II pneumocytes play in mediating alveolar
water flow is not yet well understood (10, 30). Our data
suggest that AQP4 and AQP5 are situated in the appropri-
ate membranes to facilitate transepithelial water move-
ment across type I cells. AQP3 expressed in type II cells
could modify the alveolar surface liquid by altering either
Pf or solute transport, but AQP3 localization to the baso-
lateral membrane would also require the presence of an-
other AQP in the apical membrane of type II cells.
In summary, we have identified the distribution patterns
for AQPs 3, 4, and 5 in the human nasal and lung regions
and found both similarities and differences to comparable
studies performed in animal models. We have demonstrated
expression of AQP5 in the surface epithelium of large air-
ways where a functional role for AQPs has been postulated
for replenishment of insensible water loss. Because we also
showed the presence of AQP4 in the basolateral membrane
of this airway region, it is reasonable to predict that these
two AQPs may function in a coordinated manner to achieve
transepithelial Pf. The extensive distribution of AQP3 ex-
pression in small and distal airways is perhaps the most
striking finding of this study. We speculate that in this air-
way region, AQP3 may be important in dealing with the
large volume absorption that occurs as a result of the axial
movement of water from the alveolus. Finally, we have also
shown expression of AQPs 3, 4, and 5 in the human alveo-
lar region, consistent with the requirement for transcellular
water movement as well as perhaps AQP3-specific func-
tions in type II cells. The identification of discrete AQP dis-
tribution throughout the human airways is an initial step
toward an understanding of the mechanistic physiology of
intrapulmonary surface liquid flow and its potential for
dysfunction in disease.
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